Log in to search using one of your social media accounts:

 

Princess Leia ’s Daughter Almost Played This Major Star Wars Role

Carrie Fisher’s daughter, Billie Lourd, did make an appearance in Star Wars: The Force Awakens, but apparently not in the role she was initially gunning for. During a Monday appearance on The Ellen DeGeneres Show, Lourd revealed that she met with director J. J. Abrams to discuss following in her mother’s Princess Leia footsteps by playing the lead in Episode VII of the galaxy far, far away saga. “J.J. Abrams called me to come in for Star Wars because he couldn’t find someone for the lead,” she explained, referring to the role of Rey. “He ended up finding Daisy Ridley, who’s an incredible actress — so talented! But I went in and he ended up giving me this tiny role with a couple lines. I was super excited.” Lourd also spoke about how much it meant to her to act alongside Fisher — who passed away in December at the age of 60 after suffering a heart attack — as a Resistance fighter in the film. “It was incredible,” she said. “I’m a big believer in things happening for a reason and I think I ended up in that movie for a reason. It was really incredible for us to have that experience together.” Watch the full clip below.
Source: TIME.com: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized billie lourd carrie fisher celebrities movies Princess Leia Star Wars Source Type: news

Related Links:

ANISH KOKA MD In an age where big data is king and doctors are urged to treat populations, the journey of one man still has much to tell us. This is a tale of a man named Joe. Joseph Carrigan was a bear of a man – though his wife would say he was more teddy than bear.  He loved guitar playing,  and camp horror movies.  Those who knew him well said he had a kind heart, a quick wit and loved cats. I knew none of these things when I met Joe in the Emergency Department on a Sunday afternoon.  I had been called because of an abnormal electrocardiogram – the ER team was worried he could be having ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Source Type: blogs
ANISH KOKA MD In an age where big data is king and doctors are urged to treat populations, the journey of one man still has much to tell us. This is a tale of a man named Joe. Joseph Carrigan was a bear of a man – though his wife would say he was more teddy than bear.  He loved guitar playing,  and camp horror movies.  Those who knew him well said he had a kind heart, a quick wit and loved cats. I knew none of these things when I met Joe in the Emergency Department on a Sunday afternoon.  I had been called because of an abnormal electrocardiogram – the ER team was worried he could be having ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Uncategorized Cardiac surgery High-risk Quality Reporting Source Type: blogs
ConclusionMorbidity and mortality events after ECT treatments were relatively low, supporting ECT as a low‐risk medical procedure.
Source: Acta Psychiatrica Scandinavica - Category: Psychiatry Authors: Tags: Original Article Source Type: research
(University of North Carolina at Chapel Hill) A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge the current clinical guideline that heart-attack survivors should take all three drugs -- beta blockers, ACE inhibitors and statins -- for the rest of their lives.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The Insulin Resistance Intervention After Stroke (IRIS) trial has reported that treating insulin resistance with the peroxisome proliferator –activated receptor γ agonist pioglitazone hydrochloride reduced recurrent stroke or myocardial infarction (MI) by about one-fourth compared with placebo (pioglitazone, 9.0% vs placebo, 11.8%; hazard ratio [HR], 0.76; 95% CI, 0.62-0.93) in 3876 patients with recent (
Source: JAMA Neurology - Category: Neurology Source Type: research
This secondary analysis of the Insulin Resistance Intervention After Stroke trial estimates the relative and absolute effectiveness of pioglitazone after ischemic stroke or transient ischemic attack in subgroups of patients defined by pretreatment risk for stroke or myocardial infarction.
Source: JAMA Neurology - Category: Neurology Source Type: research
In this study, researchers put some numbers to the correlation, and improve on previous attempts to rule out wealth and other effects as significant contributing causes. A study finds that a Chinese policy is unintentionally causing people in northern China to live 3.1 years less than people in the south, due to air pollution concentrations that are 46 percent higher. These findings imply that every additional 10 micrograms per cubic meter of particulate matter pollution reduces life expectancy by 0.6 years. The elevated mortality is entirely due to an increase in cardiorespiratory deaths, indicating that air poll...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
I recently asked, “Who’s to blame?” for patients not taking their medications and cited a couple of papers describing the poor state of medication adherence. I concluded nonadherence was a huge problem, and doctors failing to educate their patients was not a major cause. To support my contention that physicians are not the reason why patients do not take their medications as ordered I submit the following new information. A randomized clinical trial published online in JAMA Internal Medicine looked at patients who had been discharged after myocardial infarction and prescribed drug...
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Meds Cardiology Medications Primary Care Source Type: blogs
CONCLUSIONS: In patients with CKD, the available evidence, largely from observational studies, suggests significantly fewer events with DES vs BMS with even a lower ST rate with 2nd-generation DES. These findings should be tested in large, randomized trials. PMID: 28915510 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
Authors: Rampersad PP, Udell JA, Zawi R, Ouzounian M, Overgaard CB, Sharma V, Rao V, Farkouh ME, Džavík V Abstract BACKGROUND: Despite widespread use, evidence to support preemptive intraaortic balloon pump (IABP) insertion for patients undergoing high-risk coronary artery bypass graft (CABG) surgery remains sparse, and in need of a well-defined clinical trial. To inform the design of a prospective trial, we sought to review outcomes in randomized controlled trials (RCTs) of anticipatory IABP use vs control in patients undergoing high-risk CABG through meta-analysis. The primary endpoint was all-cause morta...
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
More News: Cardiology | Health | Heart | Heart Attack | Science